Literature DB >> 32016912

Adherence to Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review.

Natalia Świątoniowska1, Mariusz Chabowski2, Jacek Polański3, Grzegorz Mazur3, Beata Jankowska-Polańska4.   

Abstract

Adherence to therapy plays a key role in treatment optimization and clinical outcome in patients with chronic obstructive pulmonary disease (COPD). The adherence to inhaled medications is poor, ranging from 20% to 60%. In this study we searched Medline and PubMed literature regarding factors that could have an impact on therapy adherence in COPD patients, using the key words "COPD" or "chronic obstructive pulmonary disease" and "adherence". The search was limited to the English language article published between January 2013 and December 2019. Review papers, study protocols, and meta-analyses were excluded. The final material included 25 articles. The evaluation was performed using the Cochrane Review Manager guidelines. The 25 articles represented 29 countries from 5 continents. We assessed adherence to therapy and the impact of selected factors on the adherence in 27,660 COPD patients (60.9% of whom were male, mean age 64 years). The factors affecting adherence were broken down into three categories: sociodemographic, clinical, and psychological. There were two standardized instruments used in the analyzed studies: Test of Adherence to Inhalers (TAI) and self-reported Morisky Medication Adherence Scale (MMAS-8). We found that 46.3% of patients had a moderately good level of adherence to inhaled therapy (TAI range around 50 points), while 41.6% of patients had a high level of adherence to oral therapy. The nature of non-adherence was in most cases inadvertent rather than an erratic or deliberate demeanor (48.5% vs. 38.9% vs. 42.4%, respectively). We conclude that standardized instruments enable the prediction of adherence to therapy and should be used in clinical practice. The assessment of adherence is essential for undertaking interventions to counteract plausible non-adherence. Collaboration between an educator and a psychologist is required to evaluate the patient's motivation and to ensure his comprehension of treatment prescribed.

Entities:  

Keywords:  Adherence to therapy; COPD; Clinical practice; Treatment optimization

Year:  2020        PMID: 32016912     DOI: 10.1007/5584_2019_477

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease.

Authors:  Jane Turner; Qianchuan He; Kelsey Baker; Lisa Chung; Adrian Lazarevic-Fogelquist; Danika Bethune; Jesse Hubbard; Margaret Guerriero; Ajay Sheshadri; Karen L Syrjala; Paul J Martin; Michael Boeckh; Stephanie J Lee; Ted Gooley; Mary E Flowers; Guang-Shing Cheng
Journal:  Transplant Cell Ther       Date:  2021-03-26

2.  Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis.

Authors:  Yating Peng; Jiaxi Duan; Xin Li; Yuqin Zeng; Zijing Zhou; Minghua Deng; Ruoyun Ouyang; Yan Chen; Shan Cai; Ping Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-09-27

3.  The Impact of the Pay-for-Performance Program on the Outcome of COPD Patients in Taiwan After One Year.

Authors:  Kuo-Chen Cheng; Chih-Cheng Lai; Cheng-Yi Wang; Ching-Min Wang; Chung-Han Ho; Mei-I Sung; Shu-Chen Hsing; Kuang-Ming Liao; Shian-Chin Ko
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-04-21

4.  Playing the harmonica with chronic obstructive pulmonary disease. A qualitative study.

Authors:  Adam Lewis; Joy Conway; Jack Middleton; Chris K Startup; James Wyatt
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 2.444

5.  Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count.

Authors:  Linda Hartman; Maurizio Cutolo; Reinhard Bos; Daniela Opris-Belinski; Marc R Kok; Hanneke J R M Griep-Wentink; Ruth Klaasen; Cornelia F Allaart; George A W Bruyn; Hennie G Raterman; Marieke J H Voshaar; Nuno Gomes; Rui M A Pinto; L Thomas Klausch; Willem F Lems; M Boers
Journal:  Rheumatology (Oxford)       Date:  2021-11-03       Impact factor: 7.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.